Give your space a smart glow-up ...
ResMed (NYSE:RMD) is seeing growing use of wearable devices for sleep apnea pre screening, widening its reach before patients ever enter a sleep lab. Recent FDA approvals are supporting ResMed's role ...
ResMed dominates the global sleep apnea device market, boasting a 50–60% share and a high-margin razor-razor-blade business ...
In 2025, the U.S. Food and Drug Administration (“FDA”) and U.S. Department of Justice (“DOJ”) pursued significant criminal, ...
Certain Philips Respironics DreamStation breathing devices, commonly used for treating sleep apnea, may deliver the incorrect prescription or no therapy at all, the FDA warned in a recall announcement ...
AMSTERDAM – Philips has updated the use instructions for BiPAP V30, A30 and A40 ventilators due to the risk for a failure in the Ventilator Inoperative alarm, which may cause therapy interruption or ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Join Cupid Crew in sending love this Valentine’s Day Help ...
Among patients with OSA whose PAP devices were affected, 46% experienced psychological distress due to the Philips recall. When Philips Respironics issued a recall of their positive airway pressure ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Follows the company's worldwide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results